| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 42NI1P5Q1X |
Structure
| InChI Key | DZBUGLKDJFMEHC-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C13H9N |
| Molecular Weight | 179.22 |
| AlogP | 3.39 |
| Hydrogen Bond Acceptor | 1.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 0.0 |
| Polar Surface Area | 12.89 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 14.0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| DISRUPTING AGENT | DNA disrupting agent | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Central Nervous System Neoplasms | 2 | D016543 | ClinicalTrials |
| Lung Neoplasms | 2 | D008175 | ClinicalTrials |
Related Entries
Scaffolds
Cross References
| Resources | Reference |
|---|---|
| ChEBI | 36420 |
| ChEMBL | CHEMBL39677 |
| EPA CompTox | DTXSID8059766 |
| FDA SRS | 42NI1P5Q1X |
| PubChem | 9215 |
| SureChEMBL | SCHEMBL8339 |
| ZINC | ZINC000008579950 |
CONTENTS